This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Pierre Raboisson: Innovator in Pharmaceutical Chemistry
Introduction
Pierre Raboisson is a notable inventor based in Mechelen, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel compounds.
Latest Patents
Raboisson holds a patent for "Substituted 1,4-diazepines and uses thereof." This invention focuses on pharmaceutical compositions that serve as inhibitors of HDM2-p53 interactions. The compounds described in his patent have a complex structure, which includes various substituents and radicals that enhance their pharmaceutical efficacy.
Career Highlights
Pierre Raboisson is associated with Ortho-McNeil Pharmaceutical Corporation, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has led to the creation of valuable compounds that have potential therapeutic applications.
Collaborations
Raboisson has collaborated with esteemed colleagues such as Tianbao Lu and Karen L. Milkiewicz. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Pierre Raboisson's contributions to pharmaceutical chemistry through his patent and collaborative efforts highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile